Voluntis (XPAR:ALVTX) Asset Impairment Charge : €0.00 Mil (TTM As of Jun. 2021)

View and export this data going back to 2018. Start your Free Trial

What is Voluntis Asset Impairment Charge?

Voluntis's Asset Impairment Charge for the six months ended in Jun. 2021 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2021 was €0.00 Mil.

Voluntis Asset Impairment Charge Historical Data

The historical data trend for Voluntis's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voluntis Asset Impairment Charge Chart

Voluntis Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Asset Impairment Charge

Voluntis Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21
Asset Impairment Charge	Get a 7-Day Free Trial					-	-	-	-	-

Voluntis Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Voluntis Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Voluntis's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Voluntis (XPAR:ALVTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Voluntis SA (XPAR:ALVTX) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

58, Avenue de Wagram, Paris, FRA, 75017

Website

http://www.voluntis.com

Voluntis SA is engaged in developing patient-centric digital health solutions. The company offers digital solutions for diabetes, respiratory diseases, cancer, anticoagulation treatments, and haemophilia. The Company operates in a single segment: Development of therapeutic digital solutions based on its Theraxium platform.

Voluntis (XPAR:ALVTX) Headlines

No Headlines